Development and validation of a prognostic model for stage I-IIA non-small cell lung cancer: A study based on the
Sheng Wei1, Jingjing Shao2, Jinming Wang3
1Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, 226361, China.
Asian Journal of Surgery
|May 8, 2022
Abstract
No abstract available in PubMed .
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
398
05:11Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
Published on: May 10, 2024
1.2K
